IP Library › Granted Patent US 9,828,627
Granted Patent B2
US 9,828,627 · App. 14/923,319 · Granted Nov 28, 2017

Reducing DNA damage during sample preparation and sequencing using siderophore chelators

Inventors: Vincent Peter Smith (Cambridge, GB); Sohela de Rozieres (San Diego, CA)
Assignee: Illumina Cambridge Limited
C12Q1/6806C12N15/1093C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,828,627
App. No.
14/923,319
Granted
Nov 28, 2017
Kind
B2
Abstract

Embodiments disclosed herein provide reagents and kits for nucleic acid preparation comprising a siderophore. Embodiments disclosed herein provide methods for preparing a nucleic acid library, which comprise: providing a plurality of nucleic acid molecules from a sample; and manipulating the plurality of nucleic acid molecules in a reagent for nucleic acid preparation comprising a siderophore. Further, embodiments disclosed herein provide methods for reducing oxidative damage to a nucleic acid molecule or increasing the Q (phred) score of a sequencing reaction, which methods comprise preparing the nucleic acid molecule in the absence of EDTA.

Claims (17)

1. A composition for nucleic acid preparation comprising:

a reagent for nucleic acid preparation comprising a siderophore and a buffer, wherein the siderophore is present in the reagent at a concentration of 0.01 mM to 1 mM;

a plurality of oligonucleotides covalently bound to a solid support;

a plurality of nucleic acid molecules from a sample, wherein the plurality of nucleic acid molecules are hybridized to the plurality of oligonucleotides covalently bound to the solid support; and

an isolated enzyme selected from the group consisting of a DNA polymerase and a ligase;

wherein the composition does not contain EDTA, EGTA or DTPA.

2. The reagent of claim 1 , wherein the siderophore is a bacterial siderophore.

3. The reagent of claim 1 , wherein the siderophore is a desferrioxamine B (DFO-B).

4. The composition of claim 3 , wherein the DFO-B is present in the reagent at a concentration of 0.1 mM to 1 mM.

5. The composition of claim 3 , wherein the DFO-B is a mesylate salt.

6. The composition of claim 1 , wherein the enzyme is a ligase.

7. The composition of claim 1 , wherein the enzyme is a DNA polymerase.

8. The composition of claim 1 , wherein the siderophore is selected from the group consisting of desferrioxamine B, desferrioxamine E, fusarinine C, ornibactin, rhodotorulic acid, enterobactin, bacillibactin, vibriobactin, azotobactin, pyoverdine, yersiniabactin, mycobactin, ferrichrome, coprogen, arthrobactin, ferrichrome A, 2,3-dihydroxybenzoylserine, avenic acid, rhizoferrin, amonabactin T, and rhizoferrin.

9. The composition of claim 1 , wherein the solid support comprises a plurality of beads.

10. The composition of claim 1 , wherein the solid support comprises a plurality of magnetic beads.

11. The composition of claim 1 , wherein the sample comprises a biological sample.

12. The composition of claim 1 , wherein the sample is an artificial sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2016
From: SMITH, VINCENT PETER; DE ROZIERES, SOHELA
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 037469/0394 →
Continuity (2)
Provisional Application 62075708 · Nov 5, 2014
Related Publication 20160122804A1 · May 5, 2016